Introduction
Previous studies have indicated that the bleeding associated with von Willebrand's disease may be due to a defect in the ability of platelets to attach to the vascular subendothelium (1, 2) . The extent of subendothelial surface covered with platelet thrombi in those studies was diminished; however, it was suggested that this reduction was due to the abnormal platelet adhesion, since (a) platelet adhesion precedes and is necessary for thrombus formation, and (b) platelets from patients with von Willebrand's disease that had adhered to the subendothelium formed platelet thrombi to the same extent as those from controls (1, 2) .
However, it is well known that platelets from patients with von Willebrand's disease show diminished aggregation with ristocetin (3) and reduced retention (largely a measure of platelet aggregate formation) in packed bead columns (4, 5) . Also, it has recently been reported that platelets from patients with von Willebrand's disease aggregate with a microfibrillar extract only in the presence of added von Willebrand factor (6) . Thus, a defect in platelet-platelet interaction might also be possible in this disorder.
The defect in the ability of platelets from patients with von Willebrand's disease to adhere to subendothelium has been shown to increase with increasing blood shear rate (2); the reduced level of platelet adhesion on subendothelium precludes a controlled study of the nature of the plateletplatelet attachment process at high shear conditions. Thus, lower shear conditions for which the defect in adhesion was minimized were selected in order to investigate better platelet aggregate formation induced by subendothelium in von Willebrand's disease. In addition, a morphometric technique for analyzing thrombus dimensions was used to measure more precisely changes in thrombus dimensions in these studies (7) .
Methods
Procedure. An annular perfusion chamber was used to expose subendothelium to whole blood under controlled flow conditions. The procedure has been previously described (2, 7, 8) . In brief, nonanticoagulated blood from the antecubital vein was drawn directly through an infusion set (Butterfly; Abbott Hospitals Inc., North Chicago, IL) over subendothelium from everted rabbit aorta completely denuded of endothelial cells. Vessels were stored in 0.2 M Tris buffer at 4VC for 7-28 d before use. Blood was maintained at 370C by a water bath and not recirculated; flow through the chamber was controlled by a peristaltic pump (Holter; Extracorporeal Medical Specialties, Inc., King of Prussia, PA). After exposure, vessel segments were rinsed with phosphate-buffered saline and fixed with glutaraldehyde under perfusion conditions (2).
Perfusion conditions. Blood was withdrawn from the vein through the small perfusion chamber at three different flow rates: 50 ml/min for 2 min; 20 ml/min for 1.5, 3.5, and 10 min; and 10 ml/min for 5 and 10 min. These flow rates correspond to blood shear rates at the vessel surface of 3,300, 1,300, and 650 s-', respectively. These shear conditions are characteristic of flow in the smaller arteries and the microcirculation (9) . Calculation of the shear rate in the small chamber has been reported previously (2, 10).
Morphological evaluation. Evaluation of platelet interaction with subendothelium involved two separate microscopical techniques which were both performed on the same cross-sectional area of vessel segment. Vessel segments, 20 mm in length, were divided into six equal parts after the removal of 1 mm from each end. Vessels were dehydrated and embedded in epoxy resin as previously described (2, 8). Semithin sections, -0.8 Mm in thickness were prepared and all evaluations were determined at a single axial position located -10 mm from the proximal end of the original segment. A standard morphometric technique was used to evaluate the platelet-subendothelial interactions (11) . In this technique, platelet interaction with subendothelium was evaluated as (a) contact (C): platelets attached but not intimately bound to the subendothelium; (b) spread (S): platelets closely adherent to subendothelium, including small aggregates less than 5 um in height; or (c) thrombus (T): platelet aggregates extending >5 gm into the lumen. The percentage of surface coverage with platelet thrombi is defined as T divided by the total number of surface evaluations. Platelet adhesion (C + S) is the sum of all platelets attached to the surface divided by the number of evaluations. Coverage of the subendothelial surface or the platelet surface with fibrin (F) was determined at 10-Mum intervals and expressed as a percentage of the total number of evaluations -1,000 (7, 8) . Total surface coverage with fibrin is simply the numerical sum of the subendothelial and platelet coverage. Identity of fibrin was demonstrated by electron microscopy showing apparent banding of -230 A of longitudinally cut fibrin strands.
A second morphometric technique was used to investigate more precisely the extent and shape of platelet aggregates formed on subendothelium. Vessel sections previously evaluated by the standard technique were projected onto the recording plate of a manual optical picture analysis system (MOP/AMOI; Kontron Elektronik GmbH A.G., Switzerland). The total cross-sectional area of the deposited thrombi was determined mathematically by the MOP system from individual traces of the perimeter of each thrombus in the projected section. Normalization of the thrombus area by the vessel circumference (perimeter of the projected vessel section) results in the thrombus cross-sectional area per unit length of vessel segment circumference, which corresponds stereologically to the total volume of the platelet thrombi associated with a unit surface area of subendothelium (7) . The thrombus height distribution was determined by tracing the height of all thrombi in the cross-sectional view. The distribution is expressed as the total number of thrombi of heights located in the following ranges: 5-10, 10-20, 20-40, and >40 Mm (7). The maximum thrombus height is defined as the mean of the three highest values obtained from the thrombus height distribution.
Factor VIII-related values. The values reported for the various Factor VIII-related properties were obtained by previously described methods and included. Factor VIII-coagulant activity (VIII:C)' (12); Factor VIII-related antigen (VIIIR:Ag) by immunoradiometric assay (IRMA) (12) 
Results
In the present investigation a range of experimental flow conditions for studying blood-vessel wall interaction has been investigated in normal controls and patients with von Willebrand's disease. Blood from patients with severe classical hemophilia and afibrinogenemia was also studied.
Blood flow of 50 ml/min (wall shear rate of 3,300 s-). Values of platelet adhesion (C + S) from patients with von Willebrand's disease were significantly lower (P < 0.01) than those from either normal controls or patients with severe hemophilia (Table II) .
An evaluation of thrombus dimensions is given in Table  II B. As expected from the decreased levels of platelet adhesion, the von Willebrand's patients exhibit severely decreased values of thrombus volume (P < 0.01) and maximum thrombus height (P < 0.001) as compared with normal controls or hemophilic patients. In both the hemophilic patients and the fibrinogen-deficient patient, the thrombus height distribution, the thrombus volume, and the maximum thrombus height were not significantly different from those in normal controls. The thrombus height distribution in von Willebrand's disease patients was depressed at all values of thrombus height, and thrombi never grew >30 ,gm in height under these conditions, as compared with peak heights of 80-140 ,um in normal controls.
Blood flow of 40 ml/min (wall shear rate of 2,600 s-'). At slightly reduced wall shear rates, values of platelet adhesion (C + S), as indicated in Table III Willebrand's disease and hemophilia is indicated at the § § 2% or lll1% level. * The percentage of the subendothelial surface covered with platelets in either the contact (C) or spread (S) stage is defined as platelet adhesion (C + S). t The percentage of the subendothelial surface covered with platelet thrombi extending >5 ,um from the surface into the lumen is defined as surface coverage with platelet thrombi (T). § The percentage of the surface, either subendothelial (subend) or platelet attached to subendothelium, covered with fibrin is defined as the total surface coverage with fibrin (F). ¶ Value is >2 SD from normal control values. ** The numbers reported for thrombus height distribution are the total number of thrombi enumerated with height in the indicated range on a cross-section of vessel segment normalized by the vessel circumference.
< 0.01) as compared with either normal controls or patients with severe hemophilia. (Fig. 1 A) . The increase in platelet adhesion in patients with von Willebrand's disease parallels that in normal controls, and platelet adhesion appears to be asymptotic to a surface coverage of <50% in these subjects.
In hemophilic patients, however, there appears to be a (Fig. 1 C) .
(Adhesion is defined as attachment only to subendothelium; the presence of fibrin strands at the surface precludes the adhesion of platelets to subendothelium but not to fibrin.)
Under these flow conditions the technique previously used to determine thrombus formation (T) suggests no defect in the ability of platelet thrombi to cover the subendothelial surface in von Willebrand's disease ( Fig. 1 B) ; on the contrary, surface coverage with platelet thrombus (T) appears greater in von Willebrand's disease patients than in normal controls or in hemophilic patients for exposure times of .3 min.
However, inspection of the resultant deposition of blood elements on the subendothelium under these flow conditions, shown in Fig. 2 At an exposure time of 3 min, as indicated in Table IV , maximum thrombus height, but not thrombus volume, is observed to be significantly decreased (P < 0.01) in von Willebrand's disease patients (25 ,um and 1.9 ,m3/1Am2, respectively) as compared with control subjects (54 Mum, 2.0 ,sm3/;4m2, respectively) or hemophilic patients (38 um, 1.4 IAm3/;m2, respectively.) The thrombus height distribution indicates significantly fewer thrombi >40 Am in height (P < 0.01) and a tendency for increased thrombi with heights between 10 and 20 lAm in von Willebrand's disease. The apparent shift in the growth distribution of platelet thrombi observed in von Willebrand's disease is indicated in Fig. 3 .
The thrombus volume and maximum thrombus height are shown graphically for exposure times up to 10 min in Fig. 4 .
Both thrombus dimensions grow at a rate that increases with exposure time. Beyond 3 min of exposure, both parameters are reduced in von Willebrand's disease patients as compared with either control subjects or hemophilic patients. The reduction in thrombus height is highly significant (P < 0.01) as compared with normal controls.
Under these shear conditions, some decrease in thrombus volume and maximum thrombus height is also noted in the hemophilic patients, but is not statistically significant, as compared with normal controls (Fig. 4 A and B) . The reduction in thrombus dimensions is significantly less in hemophilic patients than that observed in the von Willebrand's disease patients, even though the deposition of fibrin (Fig. 1 C) Thrombus volume, maximum thrombus height, and thrombus height distribution in the fibrinogen-deficient patient are not significantly different from those of normal control subjects, suggesting that some factor not related to fibrinogen or fibrin formation influences thrombus formation.
Blood flow of 10 ml/min (wall shear rate of 650 s-'). At the lowest wall shear rates used in these experiments, the pattern of platelet and fibrin interaction (Table V) is similar to that observed at 20 ml/min (Fig. 1) (Table V) at both exposure times. Surface coverage with platelet thrombus (T) is not significantly different in any of these subject groups; however, thrombus volume and maximum thrombus height are decreased in both hemophilic and von Willebrand's patients, as compared with values in normal controls. These values are statistically significant (P < 0.02) in hemophilic subjects, but only maximum thrombus height at 10 min of exposure is significant (P < 0.01) in von Willebrand's disease patients. In contrast to the results at 20 ml/min (Fig. 4) , both thrombus volume and maximum thrombus height in hemophilic patients are equal to or less than values found in von Willebrand's patients, although the differences between patient groups are not statistically significant.
The fibrinogen-deficient patient was found to be normal for all morphometric measurements, except fibrin deposition, under these flow conditions.
Discussion
In the present study, we have investigated the influence of both exposure time and blood flow rate (wall shear rate) on the interaction of blood with rabbit aorta subendothelium. Nonanticoagulated blood drawn directly from the antecubital vein was obtained from normal subjects, patients with von Willebrand's disease and hemophilia, and a single patient with severe fibrinogen deficiency.
Platelet-platelet abnormality in von Willebrand's disease. The results of this investigation confirm the previous observations that a platelet defect exists in von Willebrand's disease that is associated with platelet attachment to subendothelium (1) and that this defect in adhesion increases with increasing blood shear rate (2). The normalization of platelet adhesion (C + S) in A.
-' I l l l . necessary for thrombus formation and which is attributable to the reduced levels of the Factor VIII complex in these patients. The decreased thrombus dimensions observed predominantly at lower shear conditions in hemophilia indicate that Factor VIII:C can mediate the growth and/or stability of platelet thrombi to some extent (Fig. 4 A, Table V ). It is highly likely that the impaired formation of thrombin (or other coagulation intermediates) rather than fibrin accounts for the defect, since under most conditions studied, thrombus dimensions in the afibrinogenemic patient are normal (Tables II-V) .
At the intermediate shear rate of 1,300 s-', thrombus dimensions in von Willebrand's disease patients are significantly reduced as compared with those in both normal controls and hemophilic patients (Fig. 4 A and B) , even though values of fibrin formation are considerably reduced in hemophilic compared with von Willebrand's disease patients (Fig. I C) . Thus, VIII/VWF appears to be involved in the ability of platelets to attach to each other to form platelet thrombi.
We consider that the defect in thrombus dimensions in von Willebrand's disease is not attributable to the defect in platelet adhesion in this disorder primarily because platelet adhesion is normal at the conditions under which the thrombus formation remains abnormal. It is unlikely that the reduced dimensions arise from any delay in thrombus growth incurred by the reduced values of platelet adhesion observed in von Willebrand's disease at short exposure times (1.5 min, Fig. 1 A), since thrombus dimensions at this exposure time are in fact not significantly different from control values (Fig. 4 A  and B) , and the rate of increase in thrombus volume and maximum thrombus height in von Willebrand's disease patients remains decreased below that of normal controls, even after values of platelet adhesion (C + S) become normal. However, due to the complexity of the interactions between thrombus formation and platelet adhesion and the present state of understanding of the dynamics of these events, we cannot rule out the possibility that an alternative explanation involving only platelet adhesion and Factor VIII:C could be proposed to explain the reduced levels of thrombi in von Willebrand's disease. The present investigation does not rule out the possibility that a defective mechanism subsequent to platelet adhesion, such as platelet secretion or thromboxane formation, might influence thrombus formation; however, no such defect has been reported previously in von Willebrand's disease. At present, we favor the more likely conclusion that FVIII/VWF mediates both platelet-to-subendothelial and platelet-to-platelet interactions in von Willebrand's disease.
The relatively normal values of thrombus volume in von Willebrand's disease at the short exposure times (1.5 and 3 min, Fig. 4 A) , together with the reduced values of thrombus height, may indicate that the initial abnormality in plateletplatelet association is not the detachment of platelet masses from the surface but the deformation of thrombi by fluid forces. Under these conditions, there is little net loss of platelet mass but a significant loss of thrombus height, which results in the apparent shift in the thrombus height distribution (Fig.  3) and the altered appearance of the platelet thrombi (Fig. 2) . Such a shift is not observed in hemophilia; maximum thrombus heights are not significantly reduced from normal levels, and the appearance of platelet thrombi are normal. Levels of fibrin formation on subendothelium are low for both the von Willebrand's disease and the hemophilic patients (Fig. 1 C) and only slightly increased in the normal controls (not statistically significant) under these conditions. Thus, at these short times, the role of thrombin in thrombus stability is questionable. A more likely explanation is that the instability is due predominantly to the reduced levels of VIII/VWF in the von Willebrand's disease patients. At longer times both thrombus volume and maximum thrombus height are decreased in von Willebrand's disease (highly significant, P < 0.01) and hemophilic patients and there is a net loss of platelets from the subendothelial surface as compared with normal controls. The likeliest explanation at these exposure times is that embolization is occurring due to the disruption of platelet-platelet attachments by both (a) flow forces in the absence of stabilization by thrombin in both bleeding disorders, and (b) the presence of EXPOSURE TIME (MIN) the basic defect in platelet-platelet association, related to the reduced levels of VIII/VWF in von Willebrand's disease.
Further considerations of the Factor VIII complex, blood flow, and platelet-subendothelium interactions. In this investigation we have demonstrated that the Factor VIII complex is involved in at least three different processes that lead to the formation of platelet thrombi on vascular surfaces: platelet adhesion, platelet-platelet association, and the generation of procoagulant moieties. First, we have confirmed previous studies (1, 2) that reduced levels of plasma VIII/VWF result in a defect in the ability of platelets to adhere to subendothelium at shear rates that are high (2,600-3,300 s-') but within those normally encountered in the microcirculation. Other studies have suggested that plasma VIII/VWF binds to subendothelium and mediates to some extent platelet adhesion (18) . VIII/VWF has also been reported in the subendothelium of vessel walls (19) , and inhibition of platelet adhesion has been demonstrated by means of incubating vessels with an antibody to VIII/VWF (20 Willebrand's disease and hemophilia at the § §2%, and I 1'1% level.
vessel wall VIII/VWF on platelet adhesion requires additional study.
The defect in platetet adhesion (C + S) at high shear rates (2,600 and 3,300 s-') leads to the development of platelet thrombi that are severely reduced in extent of surface coverage, in height, and in total quantity. The severe abnormalities in thrombus deposition that are produced under these high shear rate conditions are probably due both to inhibition of platelet adhesion and to disruption of platelet-platelet bonding. The latter appears more sensitive to shear forces than does platelet adhesion (C + S), since the formation of platelet thrombi remains abnormal at flow conditions (shear rates < 1,300 s-') at which platelet adhesion in von Willebrand's disease is normal. The sensitivity of platelet-platelet interactions to shear forces parallels their sensitivity to chemical factors, such as prostacyclin. Platelet-platelet cohesion sites, but not Factor VIII binding sites on platelets, have been shown to be inhibited by prostacyclin (21 Table II for definition of C, S, T, and F. Thrombus height distribution was not determined at this set of conditions. I Value is > 2 SD different from normal control value. Subend, subendothelium.
adhesion on subendothelium than to inhibit the formation of platelet thrombi (22) . Recent studies (23, 24) have shown that the binding of VIII/VWF to the platelet surface can be mediated by either glycoprotein Ib (ristocetin induced) or glycoprotein (thrombin or ADP induced). The absence of VIII/VWF binding in von Willebrand's disease (due at least in part to the absence of VIII/VWF in their plasma) may be related to the diminished platelet-platelet interactions (thrombus deposition) observed in the present study. The results of the present study indicate a role for VIII/VWF in platelet-platelet interactions that is sensitive to shear conditions and exposure time. Whether the defect in platelet-platelet attachment in von Willebrand's disease is due entirely to diminished plasma levels of VIII/VWF or may be related in part to reduced VIII/VWF in platelet agranules remains to be determined.
It is currently held that both platelet thrombi and fibrin formation are required for the permanent arrest of bleeding.
The present study demonstrates that distinct differences in thrombus generation and fibrin deposition occur in von Willebrand's disease and hemophilia in response to changes in blood shear rate. These differences could be germane to the requirements for hemostasis in various parts of the microcirculation and thereby account, in some part, for the different patterns of clinical bleeding observed in the two disorders.
